Effect of curcumin, coenzyme Q10 and their combined effects on metabolic syndrome components in soldiers with metabolic syndrome

The effect of curcumin, coenzyme Q10 and their combined effects on metabolic syndrome components in soldiers with metabolic syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180201038585N2

Enrollment

Registered

2018-09-21

Start date

2018-07-19

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome. Endocrine, nutritional and metabolic diseases

Interventions

Intervention 1: Intervention group: 1, curcumine 500mg, Every other day, Karen co. Intervention 2: Intervention group: 2, CoQ10, 60mg, once a ,day , nature made. Intervention 3: Intervention group:3,

Eligibility

Sex/Gender

Male

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: age: 30 -50 years military personnel with metabolic syndrome

Exclusion criteria

Exclusion criteria: the use of statins in the last 3 months having a history of cardiovascular disease morbility liver, kidney Consumption alcohol and smoking supplementation and certain drugs people who have taken less than 80% of the capsules containing curcumin, quinidine Q10 and placebo.

Design outcomes

Primary

Measure	Time frame
Waist circumferefnce. Timepoint: before intervention and end of intervention. Method of measurement: measuring tape.;Fasting blood sugar. Timepoint: before intervention and end of intervention. Method of measurement: lab kit.;Triglyceride. Timepoint: before intervention and end of intervention. Method of measurement: lab kit.;Cholesterol. Timepoint: before intervention and end of intervention. Method of measurement: lab kit.;Blood presure. Timepoint: before intervention and end of intervention. Method of measurement: sphygmomonometer.	—

Measure

Time frame

Waist circumferefnce. Timepoint: before intervention and end of intervention. Method of measurement: measuring tape.;Fasting blood sugar. Timepoint: before intervention and end of intervention. Method of measurement: lab kit.;Triglyceride. Timepoint: before intervention and end of intervention. Method of measurement: lab kit.;Cholesterol. Timepoint: before intervention and end of intervention. Method of measurement: lab kit.;Blood presure. Timepoint: before intervention and end of intervention. Method of measurement: sphygmomonometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactkarim parastouei

Bagheiat-allah University of Medical Sciences

karimparastouei@gmail.com+98 21 8248 3264

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 13, 2026